Person › Details

Steven Gelone (Nabriva Therapeutics AG)

Gelone, Steven (Nabriva 20707– promoted COO joined 201412 before Spark Therapeutics + ViroPharma)

	Organisation	Nabriva Therapeutics AG
	Today	Nabriva Therapeutics GmbH
	Group	Nabriva (Group)
	Former/major organisation	Spark Therapeutics Inc.
	Group	Roche (Group)
	Product	antibiotic
	Product 2	lefamulin (BC-3781)

Record changed: 2018-08-03

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]